This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Abnormal findings on diagnostic imaging of central nervous system
R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_CENTRAL_NERVOUS_SYSTEM
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1713 |
4. Check minimum number of eventsNone |
1713 |
5. Include endpointsNone |
1713 |
6. Filter based on genotype QC (FinnGen only) |
1713 |
Control definitions (FinnGen only)
- Control exclude
- R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_FUNCTION_STUDI_WO_DIAGNOSIS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R9[0-4]
- Name in latin
- Reperta abnormia ex imagine diagnostica systematis nervosi centralis
Similar endpoints
↥List of similar endpoints to
Abnormal findings on diagnostic imaging of central nervous system
based on the number of shared cases.
Similar with more cases:
- Abnormal findings on diagnostic imaging and in function studies, without diagnosis
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1713 | 1072 | 641 |
| Unadjusted period prevalence (%) | 0.33 | 0.37 | 0.28 |
| Median age at first event (years) | 55.04 | 51.85 | 60.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1484
- Matched controls
- 14837
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
4503599627370496.0
323.0
1315
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
12.1
242.9
487
576
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
+∞
182.1
171
*
TAB00
NOMESCO Finland
Lumbar puncture
11.1
141.0
285
312
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.8
99.2
315
663
AA1AD
NOMESCO Finland
CT of head and brain
3.7
95.9
524
1888
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
12.3
92.5
174
159
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
29.3
80.1
109
40
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
61.5
74.6
87
15
N03AX14
ATC
levetiracetam; systemic
9.3
59.2
127
147
R51.80
ICD-10 Finland
Headache
3.1
52.7
349
1355
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.1
52.5
222
604
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.9
51.4
101
99
L01AX03
ATC
temozolomide; systemic
29.2
49.5
67
24
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
25.0
47.5
67
28
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.9
46.4
163
367
G35
ICD-10 Finland
Multiple sclerosis
9.6
45.3
95
105
H02AB02
ATC
dexamethasone; systemic
3.5
40.4
211
679
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
17.3
39.7
63
38
R42
ICD-10 Finland
Dizziness and giddiness
2.4
36.9
362
1730
ZXC95
NOMESCO Finland
Use of surgical navigator
14.1
35.5
61
45
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
10.4
34.8
69
69
R20.2
ICD-10 Finland
Paraesthesia of skin
3.7
34.5
164
487
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.4
33.7
82
116
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.9
31.5
138
382
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
13.4
30.3
53
41
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.2
28.7
71
103
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.8
26.8
120
338
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.6
26.0
125
373
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.1
25.6
58
74
A02BC02
ATC
pantoprazole; systemic
1.8
24.4
913
7043
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
24.3
596
4017
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
24.1
23.5
33
14
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
54.9
23.1
27
5
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
54.9
23.1
27
5
N03AF02
ATC
oxcarbazepine; oral
4.5
23.1
83
191
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.1
22.8
63
107
G44.2
ICD-10 Finland
Tension-type headache
2.3
22.5
234
1124
109
Kela drug reimbursment
Multiple sclerosis
7.0
22.4
56
83
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
7.0
22.4
56
83
N03AX18
ATC
lacosamide; systemic
12.6
20.9
37
30
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.5
20.5
61
114
130
Kela drug reimbursment
Malignant tumour
2.9
20.2
127
460
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.8
19.7
45
59
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
19.4
133
508
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
7.2
19.0
46
66
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
15.0
18.9
31
21
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
18.7
94
291
WX882
NOMESCO Finland
High dependency care
4.2
18.1
69
169
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
17.8
163
730
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.4
17.5
46
74
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
8.3
17.3
38
47
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
22.1
16.9
24
11
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
91.1
16.6
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
16.6
288
1689
N03AX16
ATC
pregabalin; oral
1.8
16.4
327
2008
AAA10
NOMESCO Finland
Biopsy through craniotomy
40.5
16.3
20
5
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
9.3
16.2
33
36
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.5
15.9
75
222
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
4.7
15.8
54
119
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
33.7
15.7
20
6
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
15.5
313
1926
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
15.4
285
1707
G93.0
ICD-10 Finland
Cerebral cysts
17.9
15.2
23
13
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
15.1
193
1007
N03AG01
ATC
valproic acid; systemic, rectal
2.6
14.9
110
439
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.4
14.8
126
546
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
9.3
14.7
30
33
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
21.3
14.7
21
10
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
14.6
244
1409
R90
ICD-10 Finland
Abnormal findings on diagnostic imaging of central nervous system
+∞
14.6
14
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
80.9
14.6
16
*
R53
ICD-10 Finland
Malaise and fatigue
1.8
14.4
288
1764
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
7.2
14.3
34
48
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
5.9
14.3
39
67
N02BE01
ATC
paracetamol; systemic, rectal
1.7
14.1
1210
10752
H02AB06
ATC
prednisolone; systemic
1.5
14.0
612
4628
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
5.5
13.8
40
74
CS494
NOMESCO Finland
Other visual field testing
4.7
13.7
46
100
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
13.5
152
752
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
4.9
13.5
43
89
R51
ICD-10 Finland
Headache
2.6
13.0
93
366
H53.1
ICD-10 Finland
Subjective visual disturbances
2.5
12.9
101
418
N05AH04
ATC
quetiapine; oral
1.8
12.8
244
1467
Z51.5
ICD-10 Finland
Palliative care
2.9
12.8
79
285
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.9
12.7
41
86
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
12.7
91
360
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
6.7
12.5
31
47
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
4.9
12.4
40
84
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
12.4
466
3379
H02AB09
ATC
hydrocortisone; systemic
4.1
12.0
46
115
N05BA04
ATC
oxazepam; oral
1.6
11.9
333
2236
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
47.0
11.9
14
*
A04AA02
ATC
granisetron; systemic, transdermal
2.6
11.8
88
353
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
11.8
288
1864
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
8.5
11.8
25
30
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
11.7
357
2452
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
6.1
11.7
31
52
S06.0
ICD-10 Finland
Concussion
2.0
11.7
161
865
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.2
11.5
115
540
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
120.9
11.4
12
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
7.7
11.2
25
33
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.1
10.8
58
192
N06AX11
ATC
mirtazapine; oral
1.5
10.7
425
3102
N03AE01
ATC
clonazepam; systemic
2.5
10.5
84
354
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
10.4
177
1023
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
110.8
10.4
11
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.6
10.4
35
78
ZXM40
NOMESCO Finland
Use of fluorescent substance
32.8
10.3
13
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
6.4
10.3
26
41
R55
ICD-10 Finland
Syncope and collapse
2.0
10.3
133
697
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.2
10.3
24
34
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
10.7
10.3
19
18
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.4
10.1
84
361
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
6.5
10.0
25
39
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
9.2
10.0
20
22
WZC30
NOMESCO Finland
Teaching
1.8
10.0
175
1022
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
14.7
10.0
16
11
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
7.7
9.9
22
29
N05CF01
ATC
zopiclone; oral
1.5
9.9
394
2865
A04AA01
ATC
ondansetron; systemic, rectal
2.3
9.8
93
424
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
13.5
9.7
16
12
N06AX21
ATC
duloxetine; oral
1.9
9.7
151
849
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
11.4
9.6
17
15
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
9.5
371
2679
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
15.1
9.5
15
10
N03AX12
ATC
gabapentin; oral
1.7
9.5
197
1212
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
9.4
47
149
SPAT1153
SPAT
Removal of sutures
1.5
9.4
397
2920
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
12.4
9.4
16
13
H53.2
ICD-10 Finland
Diplopia
3.0
9.3
53
182
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
9.2
596
4768
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
13.8
9.2
15
11
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
9.1
200
1250
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
36.9
9.0
11
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
9.0
68
279
P20
ICPC
Memory disturbance
2.0
8.9
120
637
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
18.7
8.9
13
7
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
24.2
8.9
12
5
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.1
8.8
98
480
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.7
8.8
60
232
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
8.8
246
1642
L04AX07
ATC
dimethyl fumarate; oral
9.5
8.8
17
18
SPAT1263
SPAT
Sampling
1.4
8.6
564
4504
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
8.3
8.6
18
22
C07AB07
ATC
bisoprolol; oral
1.4
8.5
512
4022
A99
ICPC
Disease/condition unspecnature/site
2.0
8.5
107
555
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.1
8.5
91
440
M54.5
ICD-10 Finland
Low back pain
1.4
8.5
421
3190
WX892
NOMESCO Finland
Monitored bed care
2.1
8.5
91
442
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.0
8.5
22
37
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.5
8.4
62
252
WF002
NOMESCO Finland
Radical radiotherapy
2.5
8.4
65
271
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
8.4
172
1052
SPAT1216
SPAT
Assessment of functional ability
1.7
8.4
172
1052
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
6.2
8.3
21
34
N02AX02
ATC
tramadol; systemic, rectal
1.4
8.2
507
3997
N06AB04
ATC
citalopram; systemic
1.5
8.1
274
1914
JN4BD
NOMESCO Finland
Extensive body CT
1.9
8.1
123
685
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
22.1
8.0
11
5
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
7.9
198
1283
H46
ICD-10 Finland
Optic neuritis
5.0
7.9
24
49
SPAT1312
SPAT
General health counselling
1.4
7.9
429
3302
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.2
7.8
77
359
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.8
342
2521
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
6.4
7.7
19
30
SPAT1301
SPAT
No procedures
1.4
7.7
394
2994
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
7.6
130
751
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
18.5
7.6
11
6
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
18.5
7.6
11
6
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
25.1
7.6
10
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
8.9
7.5
15
17
H53.4
ICD-10 Finland
Visual field defects
3.4
7.5
34
101
L28
ICPC
Limited function/disability (L)
1.7
7.5
172
1086
WX110
NOMESCO Finland
Local anesthesy
1.4
7.5
954
8439
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.4
90
460
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
80.5
7.4
8
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
7.4
353
2644
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.3
397
3044
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
+∞
7.3
7
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.5
7.3
24
54
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
7.3
191
1255
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
15.8
7.2
11
7
A02BA02
ATC
ranitidine; systemic
1.6
7.2
222
1512
A28
ICPC
Limited function/disability NOS
1.7
7.2
153
946
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
7.3
7.2
16
22
M03BX02
ATC
tizanidine; oral
1.3
7.2
814
7046
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
7.2
68
315
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
30.2
7.1
9
*
G93.99
ICD-10 Finland
Disorder of brain, unspecified
20.1
7.1
10
5
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
20.1
7.1
10
5
G41.2
ICD-10 Finland
Complex partial status epilepticus
20.1
7.1
10
5
N05BA12
ATC
alprazolam; oral
1.8
7.1
129
762
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
7.1
340
2546
TGC00
NOMESCO Finland
Bronchial lavation
4.6
7.1
23
51
J01FF01
ATC
clindamycin; systemic
1.4
7.1
336
2512
N29
ICPC
Neurological sympt/complt other
3.2
7.1
35
112
L04AA31
ATC
teriflunomide; oral
8.8
7.0
14
16
G43.9
ICD-10 Finland
Migraine, unspecified
2.0
7.0
90
473
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
4.3
6.9
24
57
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
5.9
6.9
18
31
UDC00
NOMESCO Finland
Ear microscopy
1.9
6.9
94
503
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.9
234
1633
K90
ICPC
Stroke/cerebrovascular accident
3.2
6.9
34
109
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.8
130
779
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
6.8
162
1032
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
5.1
6.8
20
40
G40.10
ICD-10 Finland
Simple partial seizures
5.3
6.8
19
36
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
6.8
112
643
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
40.2
6.8
8
*
PA2AD
NOMESCO Finland
CT angiography of brain
7.2
6.7
15
21
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
6.7
50
204
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
22.6
6.7
9
*
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
22.6
6.7
9
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.0
6.7
80
408
C07AA05
ATC
propranolol; systemic
1.5
6.6
247
1757
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
6.6
123
734
XCK00
NOMESCO Finland
Perimetry
2.0
6.5
79
406
N06AX16
ATC
venlafaxine; oral
1.6
6.5
184
1229
R03AC02
ATC
salbutamol; inhalant
1.3
6.5
680
5783
E0000UV
ATC
NA
1.3
6.4
505
4112
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
6.3
76
391
M79.1
ICD-10 Finland
Myalgia
1.6
6.3
160
1041
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
5.5
6.3
17
31
N74
ICPC
Malignant neoplasm nervous system
18.1
6.3
9
5
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
6.3
6
*
JN4AD
NOMESCO Finland
Body CT examination
1.9
6.2
83
441
N86
ICPC
Multiple sclerosis
4.3
6.2
21
49
UJF32
NOMESCO Finland
Coloscopy
1.4
6.2
287
2128
PA7DG
NOMESCO Finland
Very extended MRI examination of vessesl in brain and neck with high intensity magnet
26.8
6.2
8
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
26.8
6.2
8
*
C03CA01
ATC
furosemide; systemic
1.5
6.2
253
1830
M01AE02
ATC
naproxen; oral, rectal
1.3
6.2
754
6530
N03AX09
ATC
lamotrigine; oral
2.1
6.2
68
337
SPAT1211
SPAT
Application of soft bandage
1.8
6.2
102
588
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
6.1
213
1490
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
7.7
6.1
13
17
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
6.1
125
767
N03AF01
ATC
carbamazepine; oral, rectal
2.1
6.1
65
317
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.7
6.1
38
143
N06AX12
ATC
bupropion; oral
1.9
6.1
86
469
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
8.6
6.1
12
14
N17
ICPC
Vertigo/dizziness
1.7
6.0
131
818
R11
ICD-10 Finland
Nausea and vomiting
1.8
6.0
97
555
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
6.0
447
3598
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
6.0
124
763
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
263
102
30.28
307.65
1.1
1.1
242.04
237.98
mg/l
0.07
224
87
259
106
28.61
307.65
1.1
1.1
—
—
—
0
0
264
106
29.26
307.65
1.2
1.2
42.41
37.54
mg/l
0.51
208
83
396
360
14.01
307.65
1.4
1.7
463.72
502.48
mg/l
0.69
378
339
321
319
12.15
294.09
1.3
1.7
3.63
3.75
mmol/l
0.94
296
301
223
134
18.98
272.60
1.1
1.1
—
—
—
0
0
302
318
11.32
264.97
1.4
1.9
49.35
22.02
e6/l
0.28
229
252
302
318
11.32
264.97
1.4
1.9
229.51
1511.35
e6/l
0.83
237
260
189
90
23.48
256.03
1.1
1.1
1.02
1.07
u/l
0.43
95
48
163
100
17.91
196.18
1.3
1.5
1.89
1.92
mmol/l
0.08
150
94
382
988
4.69
138.06
2.8
2.7
10.11
10.61
g/l
1.53
329
910
358
892
4.81
135.38
1.4
1.3
52.81
41.73
au/ml
—
8
45
373
984
4.57
130.99
2.6
2.4
32.69
21.56
au/ml
—
7
65
79
26
31.81
121.12
1.2
1.3
—
—
—
0
0
808
3846
3.08
112.24
2.4
2.1
160.57
223.53
u/l
1.44
780
3621
87
49
18.65
108.40
1.1
1.1
542.35
408.11
ng/l
—
26
9
120
132
9.70
100.02
1.6
1.8
—
—
—
0
0
61
21
30.08
91.96
1.1
1.0
—
—
—
0
0
63
25
26.12
90.51
1.1
1.0
5.60
5.78
mg/g
0.10
63
25
215
509
4.69
84.82
1.8
1.8
38.31
40.08
u/l
0.62
198
452
941
5458
2.61
81.41
4.8
4.8
36.14
36.07
g/l
0.13
882
5102
81
73
11.60
77.44
1.2
1.1
—
—
—
0
0
1024
6316
2.54
75.78
7.6
6.6
1.21
1.21
mmol/l
0.03
848
5336
1169
7760
2.59
72.55
5.8
4.8
6.45
6.60
mmol/l
1.79
1114
7204
75
68
11.49
71.38
1.4
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
78
78
10.43
69.44
1.3
1.1
—
—
—
0
0
443
1909
2.78
68.10
2.1
2.2
29.28
29.56
s
0.31
432
1848
41
10
41.98
67.79
1.1
1.0
—
—
—
0
0
930
5725
2.37
65.61
6.9
6.0
1.21
1.21
mmol/l
0.16
866
5200
53
34
16.05
61.65
1.2
1.1
—
—
—
0
0
328
1291
2.91
59.04
2.6
2.1
362.08
376.52
nmol/l
0.64
309
1187
52
35
15.29
58.96
1.2
1.1
—
—
—
0
0
111
205
5.72
57.86
1.2
1.1
—
—
—
0
0
53
39
13.99
57.21
1.2
1.2
—
—
—
0
0
1025
6832
2.25
56.50
7.5
5.9
10.33
11.40
umol/l
2.08
974
6476
52
38
14.08
56.35
1.2
1.2
—
—
—
0
0
72
86
8.70
56.05
2.8
3.0
0.23
0.22
e9/l
0.22
66
75
1145
8012
2.29
55.65
11.4
8.8
4.16
4.02
e9/l
0.79
1027
6991
72
89
8.40
54.52
2.8
2.9
534.89
636.76
e6/l
0.40
65
76
40
20
20.45
52.21
1.9
2.9
—
—
—
0
0
776
4745
2.16
51.67
3.9
3.3
28.87
49.67
ng/l
1.40
523
2984
49
39
12.90
50.48
1.2
1.1
—
—
—
0
0
251
925
3.01
50.41
2.2
3.1
67.61
66.95
g/l
0.67
233
851
53
48
11.36
50.36
1.2
1.2
—
—
—
0
0
1331
10194
2.37
48.21
5.1
3.7
10.71
10.94
mm/h
0.26
1254
9484
984
6770
2.07
45.95
8.2
5.9
28.08
28.88
%
1.37
941
6346
973
6681
2.06
45.51
7.7
5.7
57.24
56.49
%
1.08
933
6287
1340
10430
2.31
44.44
9.6
6.9
74.37
77.20
u/l
1.67
1278
9807
42
35
12.28
42.02
3.0
1.8
—
—
—
0
0
137
396
3.67
40.56
1.9
1.5
0.04
0.02
iu/ml
0.59
23
65
61
88
7.15
40.42
2.3
3.0
13.52
11.93
%
0.29
27
54
32
20
16.29
37.53
1.3
1.3
—
—
—
0
0
113
302
3.94
37.41
1.8
2.0
11.02
11.22
mg/l
0.04
106
275
59
91
6.68
36.75
1.2
1.2
—
—
—
0
0
36
29
12.66
36.73
1.2
1.2
—
—
—
0
0
30
18
16.95
35.88
1.3
1.3
—
—
—
0
0
25
10
25.36
35.38
1.2
1.1
—
—
—
0
0
45
54
8.53
34.82
1.0
1.0
—
—
—
0
0
58
95
6.28
34.09
2.8
2.3
981.86
829.64
e6/l
0.51
42
33
1222
9590
1.96
33.65
3.9
3.0
47.28
44.60
u/l
0.44
1161
9034
24
10
24.33
33.43
1.3
1.4
—
—
—
0
0
70
141
5.13
33.07
1.2
1.0
—
—
—
0
0
98
260
3.94
32.75
2.4
2.6
—
—
—
0
0
1622
14330
3.48
32.69
20.2
13.8
139.54
139.66
mmol/l
1.19
1599
13961
78
175
4.62
32.45
1.5
1.8
—
1337.14
—
0
7
1623
14371
3.46
32.03
20.2
13.9
3.94
3.95
mmol/l
1.21
1596
13979
132
440
3.17
31.11
2.0
1.7
—
—
—
0
0
69
145
4.92
31.04
2.1
2.4
19.12
20.83
nmol/l
0.74
69
135
41
51
8.21
30.81
1.1
1.1
—
—
—
0
0
23
11
21.18
30.33
1.1
1.1
—
—
—
0
0
371
2037
2.05
29.91
3.7
3.6
0.82
0.82
mmol/l
0.65
349
1918
29
23
12.81
29.80
1.2
1.3
—
—
—
0
0
1607
14245
3.07
29.73
19.2
12.1
19.01
22.38
mg/l
4.67
1367
11005
62
128
4.99
28.48
1.4
1.4
—
—
—
0
0
22
11
20.25
28.45
1.2
1.4
—
—
—
0
0
45
70
6.58
27.79
1.2
1.1
1896.22
1518.44
miu/ml
0.85
45
70
793
5649
1.75
27.67
2.6
2.2
76.88
75.88
nmol/l
0.42
728
5121
79
204
4.01
27.39
1.4
1.1
—
—
—
0
0
1334
11074
1.92
27.33
4.8
4.0
14.76
14.64
pmol/l
0.97
1236
10182
533
3394
1.83
27.17
3.9
3.9
93.87
92.07
%
0.96
522
3302
22
13
17.13
26.37
1.1
2.5
—
—
—
0
0
1141
9077
1.77
26.28
5.2
4.1
3146.29
2356.66
e6/l
0.10
14
120
1499
13064
2.18
25.34
5.6
4.7
1.78
2.08
mu/l
1.21
1410
12100
49
91
5.51
25.32
1.5
1.8
—
—
—
0
0
607
4093
1.75
25.05
2.9
2.5
55.08
56.34
u/l
0.27
559
3802
340
1921
1.96
24.82
1.9
1.8
—
—
—
0
0
46
84
5.60
24.20
2.5
3.1
—
—
—
0
0
869
6501
1.68
24.19
4.5
3.9
—
—
—
0
0
211
1010
2.24
23.89
3.8
3.6
1.22
1.23
mmol/l
0.80
196
864
371
2194
1.88
23.47
1.7
1.7
1097.84
1165.56
nmol/l
0.75
289
1669
24
21
11.58
23.15
1.8
1.4
—
—
—
0
0
111
397
2.92
23.09
1.8
1.5
585.00
138.33
titre
—
5
12
124
476
2.73
22.61
2.2
1.8
—
—
—
0
0
251
1315
2.06
22.50
8.3
8.4
0.80
1.00
mmol/l
0.31
194
1026
252
1324
2.06
22.41
4.8
4.2
225.33
248.96
u/l
1.76
233
1255
628
4382
1.68
22.24
3.4
3.3
2.35
2.35
mmol/l
0.27
542
3858
20
15
13.48
21.11
1.2
1.3
—
—
—
0
0
111
420
2.76
20.80
2.0
2.2
754.19
426.01
ug/l
0.34
103
390
709
5184
1.63
20.44
2.1
1.9
100.34
95.74
pmol/l
1.65
405
2728
49
110
4.56
20.39
1.4
1.5
—
—
—
0
0
82
266
3.19
20.20
3.9
3.7
2.41
2.39
mmol/l
0.02
56
179
642
4591
1.64
20.18
3.4
3.2
28.86
31.21
u/l
1.38
606
4378
244
1324
1.98
19.70
8.4
8.4
4.99
5.09
kpa
0.82
233
1263
244
1324
1.98
19.70
8.4
8.4
14.06
12.66
kpa
2.92
234
1267
1637
15111
2.88
19.39
13.9
9.4
26.23
26.18
u/l
0.03
1600
14625
421
2723
1.72
19.26
1.7
1.6
446.10
44517400.82
pmol/l
3.52
340
2298
21
20
10.62
19.13
1.9
1.1
47.30
49.13
%
—
10
8
877
6832
1.58
18.86
5.4
4.5
0.00
0.00
estimate
0.50
193
1296
165
788
2.21
18.66
4.8
3.7
5.15
5.16
kpa
0.03
151
744
883
6902
1.58
18.62
4.0
3.3
0.00
0.00
estimate
0.80
186
1247
164
783
2.21
18.56
2.5
1.9
1.18
1.37
g/l
0.86
157
727
872
6800
1.58
18.56
3.9
3.3
0.00
0.00
estimate
0.50
189
1264
126
541
2.43
18.23
1.2
1.2
0.22
0.94
u/ml
—
9
46
20
20
10.11
17.61
1.1
1.1
—
—
—
0
0
20
20
10.11
17.61
1.1
1.1
—
—
—
0
0
214
1163
1.96
17.10
9.1
9.0
96.95
95.84
%
2.74
207
1126
203
1088
1.98
16.87
9.4
9.2
123.97
122.00
g/l
0.70
198
1050
99
395
2.60
16.72
1.2
1.1
—
—
—
0
0
471
3252
1.62
16.36
2.6
2.2
—
—
—
0
0
75
263
2.94
16.19
3.0
3.3
34.74
35.32
umol/l
0.06
58
225
153
755
2.13
15.90
4.9
3.7
1.60
1.61
mmol/l
0.01
103
562
547
3965
1.56
15.24
3.6
3.0
20.36
93.18
e6/l
2.57
442
3014
37
85
4.43
15.00
1.1
1.3
—
—
—
0
0
273
1668
1.76
14.93
6.0
5.8
1.03
1.05
mmol/l
0.68
261
1549
66
228
2.97
14.65
1.2
1.7
—
—
—
0
0
100
428
2.42
14.58
1.7
1.9
—
—
—
0
0
684
5250
1.50
14.41
4.2
3.4
—
—
—
0
0
106
470
2.34
14.28
1.6
1.4
9.58
9.76
u/l
0.05
90
373
20
9
22.46
14.22
1.0
1.0
—
—
—
0
0
368
2470
1.62
14.06
1.3
1.3
24.81
27.11
iu/ml
0.15
117
759
399
2737
1.60
13.92
3.0
2.4
5.22
6.86
e6/l
1.88
359
2398
73
276
2.72
13.74
2.6
2.7
24.32
24.75
mmol/l
0.32
59
244
498
3618
1.53
13.40
3.5
3.0
0.24
0.44
e6/l
2.66
396
2699
35
85
4.18
13.25
2.6
2.5
45.25
40.75
%
0.51
16
27
67
249
2.76
13.04
2.9
6.1
194.83
300.53
iu/ml
—
6
36
137
701
2.04
12.91
8.6
7.9
24.42
24.46
mmol/l
0.04
132
655
18
24
7.57
12.71
1.2
1.2
—
—
—
0
0
1480
13508
1.70
12.69
4.6
4.1
5.82
5.84
mmol/l
0.20
1357
12434
192
1108
1.83
12.64
3.9
4.7
1.61
1.76
mmol/l
0.29
152
880
1454
13218
1.66
12.56
16.4
11.2
86.10
85.12
ml/min/173m2
1.01
1258
10788
59
211
2.86
12.35
3.3
6.0
370.27
370.74
umol/l
0.01
51
185
1398
12611
1.59
12.20
5.6
5.2
38.69
39.18
mmol/mol
1.36
1296
11778
127
647
2.04
12.12
2.1
1.6
277.04
304.97
mu/l
0.78
121
583
32
81
4.01
11.49
1.1
1.0
29.70
44.27
ng/l
1.34
25
46
32
81
4.01
11.49
1.1
1.0
271.79
285.04
ng/l
0.06
26
49
54
192
2.87
11.44
1.3
1.3
—
—
—
0
0
16
21
7.68
11.43
1.1
1.2
—
—
—
0
0
81
353
2.36
11.39
1.7
1.7
—
—
—
0
0
1676
16043
3.07
11.35
28.4
18.1
4.47
4.52
e12/l
4.71
1649
15617
1675
16029
3.03
11.33
28.4
18.1
255.51
254.72
e9/l
0.18
1653
15645
1676
16048
3.05
11.24
28.4
18.1
6.96
6.70
e9/l
1.69
1650
15623
63
247
2.61
11.09
2.7
2.4
16.06
16.30
%
0.16
24
118
1675
16048
2.97
10.94
28.5
18.2
134.66
135.91
g/l
3.29
1662
15834
422
3083
1.49
10.68
2.1
1.8
1.10
1.06
mg/l
0.08
315
2295
31
81
3.88
10.68
1.1
1.0
723.77
699.24
ng/l
0.09
26
49
402
2915
1.50
10.54
1.6
1.5
21.04
20.87
nmol/l
0.03
361
2504
329
2290
1.54
10.45
2.3
2.9
2.44
2.44
mmol/l
0.23
295
2015
88
413
2.19
10.41
1.4
1.3
—
—
—
0
0
244
1595
1.62
10.14
4.2
4.1
33.34
31.91
%
1.21
186
1107
134
741
1.88
10.09
11.2
10.2
94.78
93.93
%
1.08
134
736
152
876
1.81
10.03
2.0
1.7
—
—
—
0
0
442
3304
1.46
9.84
2.3
2.1
2.91
2.88
mg/l
0.10
392
2812
775
6399
1.39
9.76
3.3
2.8
114.51
110.80
ug/l
0.20
731
5959
93
458
2.09
9.75
5.2
6.4
1.76
1.58
%
0.86
85
426
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
79
366
2.21
9.66
3.2
3.3
0.41
0.37
u/ml
0.51
55
208
22
48
4.63
9.54
1.6
1.3
—
—
—
0
0
22
48
4.63
9.54
1.6
1.3
—
—
—
0
0
22
48
4.63
9.54
1.6
1.3
—
—
—
0
0
22
48
4.63
9.54
1.6
1.3
—
—
—
0
0
87
423
2.11
9.44
2.2
2.0
2.04
1.92
ug/l
0.04
74
377
474
3631
1.42
9.13
4.4
3.6
0.00
0.01
estimate
1.28
192
1253
429
3228
1.44
9.12
3.0
2.9
878.45
1095.66
ng/l
0.98
366
2711
19
38
5.04
9.10
1.8
1.4
—
—
—
0
0
125
700
1.85
9.06
2.6
2.2
4259.48
5225.87
u/l
0.14
40
284
390
2888
1.45
9.02
1.7
1.5
2.45
2.28
g/l
0.62
267
1768
331
2374
1.49
9.01
3.5
3.4
213.34
406.57
ng/l
1.33
215
1684
13
7
18.70
8.93
1.3
7.6
—
—
—
0
0
231
1543
1.57
8.72
6.7
6.1
—
—
—
0
0
308
2192
1.49
8.69
3.0
2.6
1.49
1.02
e6/l
0.88
180
1219
42
152
2.81
8.68
1.9
1.4
280.67
281.81
mosm/kgh2o
0.14
36
114
203
1317
1.61
8.66
3.2
2.8
1.69
1.76
%
0.49
181
1184
13
8
16.37
8.55
1.2
1.1
—
—
—
0
0
18
37
4.91
8.36
1.6
1.4
—
—
—
0
0
18
37
4.91
8.36
1.6
1.4
—
—
—
0
0
113
629
1.85
8.36
11.8
11.5
—
—
—
0
0
46
180
2.60
8.20
1.3
1.3
—
—
—
0
0
150
914
1.70
8.16
3.3
3.2
4.43
4.55
pmol/l
0.68
135
811
324
2361
1.46
8.07
1.3
1.3
11.19
10.44
u/ml
0.07
119
949
15
27
5.60
8.02
1.9
2.2
—
—
—
0
0
261
1828
1.50
7.92
1.9
1.8
1.56
1.45
%
1.09
231
1629
201
1331
1.58
7.86
1.7
1.7
—
—
—
0
0
93
496
1.93
7.85
1.9
2.0
1.46
1.51
g/l
0.16
76
439
202
1345
1.57
7.71
1.7
1.7
—
—
—
0
0
257
1804
1.50
7.70
2.6
2.4
2.30
2.37
g/l
1.04
241
1672
155
972
1.65
7.57
2.6
2.2
12.61
12.75
nmol/l
0.06
141
859
29
92
3.19
7.55
1.6
1.5
—
—
—
0
0
69
337
2.09
7.45
2.7
4.1
36.81
69.68
mg/l
1.03
53
272
69
337
2.09
7.45
2.7
4.1
22.18
34.20
mg/l
2.73
53
273
40
154
2.64
7.39
6.5
6.7
11.85
11.28
mg/l
0.34
40
143
166
1066
1.62
7.38
8.4
8.0
1.49
1.35
mmol/l
0.45
159
1023
47
197
2.42
7.30
2.2
3.8
190.00
3133.69
u/ml
—
5
13
38
144
2.68
7.25
1.3
1.3
—
—
—
0
0
54
242
2.27
7.22
1.2
1.2
3.53
5.88
u/ml
0.69
19
102
273
1975
1.45
7.00
2.7
2.4
13.72
13.75
umol/l
0.02
254
1821
26
81
3.24
6.98
1.2
1.1
1.07
1.06
ratio
—
7
35
118
705
1.72
6.92
1.3
1.4
—
—
—
0
0
37
142
2.64
6.90
1.1
1.2
—
—
—
0
0
117
698
1.73
6.90
1.6
1.6
—
—
—
0
0
237
1673
1.48
6.88
2.7
2.4
23.88
23.72
%
0.06
204
1434
37
143
2.62
6.81
1.4
1.4
—
—
—
0
0
74
384
1.97
6.80
1.2
1.2
13.10
41.80
u/ml
—
8
21
58
276
2.14
6.73
1.5
1.6
—
—
—
0
0
95
538
1.81
6.69
6.3
4.1
25.12
24.78
mmol/l
0.68
89
507
64
317
2.06
6.69
5.9
4.3
8.50
8.57
kpa
0.11
58
297
53
244
2.21
6.67
1.2
1.2
1.65
4.67
u/ml
1.47
17
79
58
278
2.12
6.61
1.6
1.3
—
—
—
0
0
11
9
12.29
6.58
1.0
1.1
—
—
—
0
0
22
64
3.47
6.57
1.1
1.2
—
—
—
0
0
57
273
2.13
6.51
1.3
1.5
0.29
0.35
nmol/l
0.43
41
221
10
7
14.36
6.40
1.0
1.1
—
—
—
0
0
57
276
2.10
6.34
4.5
3.7
58.21
57.31
%
0.18
57
276
27
92
2.97
6.28
1.0
1.1
0.14
2.29
nmol/l
—
6
13
63
319
2.01
6.23
1.3
1.3
—
—
—
0
0
30
110
2.76
6.13
2.4
2.5
—
—
—
0
0
75
408
1.88
6.03
2.4
2.7
9.97
10.28
g/l
0.28
66
354
142
923
1.59
6.03
1.3
1.3
210.66
215.61
u/ml
0.02
131
854
149
980
1.57
6.01
1.9
2.4
4.16
6.60
ug/l
2.88
131
864
26
89
2.95
6.01
1.5
1.3
—
—
—
0
0
26
89
2.95
6.01
1.5
1.3
—
—
—
0
0
26
89
2.95
6.01
1.5
1.3
—
—
—
0
0
68
359
1.93
5.98
1.2
1.2
2.79
10.35
u/ml
—
10
61
29
106
2.77
5.96
2.8
3.0
57.58
53.70
%
0.45
24
77
18
49
3.70
5.92
3.0
2.8
31.62
31.62
umol/l
—
10
37
39
167
2.37
5.84
1.4
1.3
—
—
—
0
0
169
1153
1.52
5.79
3.3
4.2
5.44
24.16
ug/l
1.67
136
930
53
261
2.06
5.67
7.2
8.9
106.02
105.70
mmol/l
0.21
48
233
248
1832
1.41
5.63
2.7
2.4
126.17
109.85
ug/g
0.51
195
1456
22
71
3.13
5.62
1.4
1.4
—
—
—
0
0
19
56
3.42
5.59
1.4
3.6
171.75
139.29
umol/l
—
8
31
274
2066
1.39
5.52
3.1
2.8
2.74
2.74
e6/l
0.00
147
1096
77
437
1.80
5.44
2.4
2.6
7.34
7.38
g/l
0.06
61
342
77
437
1.80
5.44
2.4
2.6
—
—
—
0
0
416
3353
1.32
5.41
1.3
1.3
1.48
1.47
u/ml
0.00
112
902
41
187
2.22
5.34
1.5
1.6
—
—
—
0
0
65
354
1.87
5.25
1.2
1.2
1.80
2.59
u/ml
—
5
39
1488
14134
1.40
5.23
4.8
4.5
2.74
2.80
mmol/l
1.79
1365
13169
53
270
1.99
5.20
1.4
1.6
—
—
—
0
0
1469
13928
1.38
5.18
4.4
4.1
4.63
4.70
mmol/l
2.28
1359
13062
76
437
1.77
5.16
2.4
2.6
3.52
3.77
g/l
0.94
59
328
1422
13420
1.35
5.12
18.4
13.4
39.18
40.06
%
2.68
993
10217
8
6
13.39
5.08
1.0
1.2
—
—
—
0
0
128
847
1.55
5.06
1.5
1.4
21.65
26.96
iu/l
1.23
115
708
370
2962
1.32
5.01
4.1
3.6
1.02
1.02
kg/l
0.14
54
415
170
1199
1.46
4.96
2.7
2.3
0.22
0.22
g/l
0.65
157
1123
28
112
2.52
4.88
1.1
1.4
1.34
1.20
promille
0.18
23
89
12
28
4.31
4.83
1.1
1.1
—
—
—
0
0
8
7
11.47
4.78
1.0
1.0
—
—
—
0
0
414
3389
1.29
4.73
3.2
2.5
2821.26
4808.53
umol/l
0.52
367
2974
1457
13839
1.35
4.72
4.4
4.1
1.46
1.47
mmol/l
0.67
1348
12904
32
139
2.33
4.70
1.7
2.2
24.00
28.14
mg/l
—
6
38
12
29
4.16
4.63
1.1
1.1
—
—
—
0
0
71
415
1.74
4.59
2.5
2.7
3.08
3.13
g/l
0.16
60
335
48
248
1.96
4.57
2.4
2.2
127.03
130.16
g/l
0.38
36
191
23
87
2.67
4.49
1.0
1.1
—
—
—
0
0
182
1326
1.42
4.47
4.5
3.1
—
—
—
0
0
66
384
1.75
4.35
1.5
1.5
316.59
292.83
ug/g
0.47
37
217
155
1103
1.45
4.34
1.2
1.2
172.24
151.27
iu/ml
0.20
62
424
1406
13327
1.31
4.31
4.0
3.7
1.28
1.28
mmol/l
0.07
1297
12378
205
1535
1.38
4.30
2.8
2.8
7.74
7.90
umol/l
0.05
180
1328
54
297
1.84
4.28
1.1
1.2
24.28
39.21
u/ml
—
5
31
26
108
2.43
4.23
1.3
1.0
264.12
290.74
mg/l
0.87
26
95
16
51
3.16
4.21
2.1
2.6
—
—
—
0
0
33
156
2.14
4.01
1.7
1.4
—
—
—
0
0
33
156
2.14
4.01
1.7
1.4
—
—
—
0
0
56
319
1.78
3.99
2.8
2.7
0.00
0.00
g/l
0.00
56
299
46
247
1.89
3.95
1.4
1.4
23.81
24.67
u/l
0.06
37
203
33
157
2.12
3.95
1.7
1.4
—
—
—
0
0
33
157
2.12
3.95
1.8
1.4
—
—
—
0
0
64
382
1.70
3.89
2.0
1.9
4.22
5.34
iu/l
0.54
29
130
33
159
2.10
3.83
1.8
1.4
—
—
—
0
0
17
60
2.85
3.79
1.5
1.5
—
—
—
0
0
17
60
2.85
3.79
1.5
1.5
—
—
—
0
0
55
317
1.76
3.78
2.9
2.7
0.00
0.00
g/l
0.00
55
298
15
50
3.02
3.69
2.4
2.4
—
—
—
0
0
15
51
2.96
3.57
1.3
1.3
—
—
—
0
0
64
394
1.65
3.49
2.0
1.7
42.14
40.17
nmol/l
0.23
59
377
25
112
2.25
3.49
1.4
1.3
152558.85
97619.60
e6/l
0.15
13
77
32
159
2.03
3.46
1.8
1.4
—
—
—
0
0
38
202
1.90
3.40
3.7
3.8
33.55
1876.58
u/ml
0.84
31
189
9
18
5.02
3.37
2.3
1.9
—
—
—
0
0
22
97
2.28
3.20
1.5
1.2
—
—
—
0
0
22
98
2.26
3.13
1.5
1.2
—
—
—
0
0
21
92
2.30
3.10
1.2
1.2
—
—
—
0
0
41
231
1.79
3.09
1.1
1.1
—
—
—
0
0
12
39
3.09
3.09
1.3
2.4
—
74168.83
—
0
6
10
29
3.46
3.05
5.2
5.1
—
—
—
0
0
1075
10039
1.19
3.02
3.5
3.3
—
—
—
0
0
5
5
10.02
2.98
1.4
11.8
—
—
—
0
0
39
220
1.79
2.95
1.1
1.1
130.33
116.80
%
1.34
33
204
15
58
2.60
2.87
1.0
1.1
106.60
92.28
%
—
10
50
11
36
3.07
2.81
2.5
2.1
20.83
17.57
umol/l
0.30
11
36
29
151
1.94
2.80
1.6
1.6
55.76
57.21
%
0.07
21
96
127
947
1.37
2.79
3.7
3.9
78.03
81.95
ng/l
0.16
113
836
10
31
3.24
2.77
1.1
1.1
—
—
—
0
0
7
14
5.02
2.73
1.4
1.4
—
—
—
0
0
31
167
1.87
2.72
1.3
1.3
—
—
—
0
0
21
98
2.16
2.71
1.3
1.2
—
87.25
—
0
8
6
10
6.02
2.70
3.0
1.1
41.33
48.60
%
—
6
5
9
24
3.76
2.67
1.0
1.2
—
—
—
0
0
24
119
2.03
2.66
1.0
1.0
—
—
—
0
0
28
149
1.89
2.56
2.2
2.2
32.93
32.48
pg
0.22
28
149
32
178
1.81
2.56
1.1
1.3
—
0.29
nmol/l
—
0
16
182
1453
1.28
2.51
17.4
21.2
1.09
1.25
inr
2.41
47
204
47
295
1.61
2.46
1.8
1.7
12879.75
13648.46
e6/l
0.06
36
217
408
3566
1.19
2.39
4.3
4.6
3.98
2.36
ug/l
0.53
350
3199
15
65
2.32
2.31
1.5
1.6
—
—
—
0
0
26
141
1.86
2.28
1.5
1.4
227.09
340.59
pmol/l
1.63
17
105
44
278
1.60
2.27
1.6
1.9
—
—
—
0
0
7
18
3.90
2.25
1.3
1.3
—
—
—
0
0
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
43
272
1.60
2.21
1.5
1.7
—
—
—
0
0
13
54
2.42
2.20
1.5
1.6
—
1224630.00
—
0
5
18
87
2.08
2.17
1.6
1.6
—
—
—
0
0
229
1918
1.22
2.10
2.1
2.0
—
—
—
0
0
16
75
2.14
2.08
1.1
1.0
—
—
—
0
0
35
215
1.64
2.04
1.2
1.1
—
—
—
0
0
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
6
15
4.01
2.04
2.0
2.5
—
—
—
0
0
1269
12175
1.16
2.03
21.4
15.1
13.66
13.57
%
1.30
1255
11920
11
44
2.51
2.01
1.3
1.4
14.19
14.19
pmol/l
0.00
11
36
429
3816
1.17
2.01
4.2
4.0
11.18
8.69
mg/mmol
0.34
268
2427
9
32
2.82
2.00
2.2
2.7
—
—
—
0
0
9
32
2.82
2.00
2.2
2.7
—
—
—
0
0
17
84
2.03
1.96
3.6
3.6
—
—
—
0
0
43
282
1.54
1.93
1.1
1.1
4.70
4.57
u/ml
0.02
19
152
28
165
1.71
1.91
1.4
1.6
—
—
—
0
0
42
275
1.54
1.90
1.0
1.1
0.51
1.57
u/ml
1.03
11
124
16
79
2.03
1.85
1.6
2.0
—
—
—
0
0
454
4079
1.15
1.85
3.4
3.3
7.79
7.76
mmol/l
0.05
379
3480
23
130
1.78
1.82
1.5
1.8
—
—
—
0
0
6
18
3.34
1.74
2.0
2.3
—
—
—
0
0
49
339
1.46
1.74
1.2
1.2
—
—
—
0
0
13
61
2.14
1.71
22.3
29.7
84.38
126.74
ug/l
2.19
13
52
97
755
1.30
1.69
3.2
3.0
69.67
48.51
u/ml
0.38
91
737
30
187
1.62
1.69
1.2
1.3
—
—
—
0
0
405
3633
1.15
1.68
3.4
3.3
880.70
354.12
mg/l
0.77
267
2328
10
42
2.39
1.67
1.4
1.3
—
—
—
0
0
46
317
1.46
1.67
1.2
1.3
—
—
—
0
0
66
488
1.37
1.64
2.2
1.8
—
—
—
0
0
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
34
225
1.52
1.52
1.7
2.3
5.88
6.78
umol/l
0.20
18
168
11
51
2.16
1.50
1.5
1.1
—
—
—
0
0
81
632
1.30
1.43
4.4
5.5
23.67
24.08
mmol/l
0.71
71
573
336
3011
1.14
1.42
1.6
1.6
—
—
—
0
0
7
29
2.42
1.39
1.3
1.1
80.57
97.66
%
—
7
29
7
29
2.42
1.39
1.3
1.1
—
—
—
0
0
30
198
1.52
1.38
1.0
1.1
0.45
0.32
u/ml
—
6
50
16
89
1.81
1.37
1.4
1.0
—
—
—
0
0
294
2627
1.14
1.30
1.6
1.5
—
—
—
0
0
12
217
0.55
1.26
1.0
1.1
—
—
—
0
0
16
92
1.75
1.25
1.2
1.3
—
—
—
0
0
9
45
2.01
1.23
1.1
1.9
210.22
136.35
%
—
9
40
55
418
1.33
1.20
1.1
1.1
2.67
4.88
u/ml
—
8
58
239
2126
1.14
1.14
2.1
2.1
—
—
—
0
0
16
95
1.69
1.14
1.3
1.4
77.33
74.89
pmol/l
—
8
30
11
58
1.90
1.12
1.4
1.1
77.05
76.77
u/l
0.01
11
45
11
58
1.90
1.12
1.4
1.1
23.32
22.07
u/l
0.04
11
43
16
96
1.67
1.10
2.0
1.8
1.71
2.40
u/field
—
7
47
100
832
1.21
1.07
1.1
1.0
—
—
—
0
0
34
249
1.37
0.98
1.3
1.3
—
—
—
0
0
34
249
1.37
0.98
1.3
1.3
—
—
—
0
0
32
232
1.39
0.98
1.0
1.1
4.36
4.92
u/ml
0.08
12
86
33
241
1.38
0.97
1.0
1.1
2.00
2259.12
iu/ml
0.54
14
59
10
54
1.86
0.96
1.1
1.3
—
—
—
0
0
10
54
1.86
0.96
1.1
1.3
—
—
—
0
0
43
328
1.32
0.96
1.6
1.4
—
—
—
0
0
42
546
0.76
0.96
1.5
1.5
—
—
—
0
0
17
110
1.55
0.90
1.2
1.1
—
—
—
0
0
17
110
1.55
0.90
1.2
1.1
—
—
—
0
0
42
324
1.30
0.88
1.1
1.1
5.86
1.94
u/ml
0.33
11
138
37
281
1.32
0.87
1.2
1.5
95.67
126.53
u/ml
—
9
47
17
112
1.52
0.85
1.2
1.1
—
—
—
0
0
17
112
1.52
0.85
1.2
1.1
—
—
—
0
0
17
112
1.52
0.85
1.2
1.1
—
—
—
0
0
66
543
1.22
0.83
1.3
1.4
—
—
—
0
0
11
65
1.70
0.82
1.0
1.1
112.55
242.52
iu/ml
1.54
11
65
62
508
1.23
0.82
1.6
1.7
—
—
—
0
0
118
1027
1.16
0.81
3.2
2.4
77.74
70.46
ml/min/173m2
1.15
51
408
18
122
1.48
0.80
1.3
1.2
46.20
57.19
u/l
—
10
91
15
98
1.54
0.78
1.3
1.4
—
—
—
0
0
18
123
1.47
0.77
1.1
1.5
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
10
59
1.70
0.76
1.3
1.1
0.31
0.29
g/l
—
10
51
15
100
1.50
0.73
2.0
2.0
—
—
—
0
0
5
25
2.00
0.72
1.6
2.0
6.36
7.99
mmol/l
—
5
15
10
60
1.67
0.72
2.9
2.3
24.56
158.89
ug/l
—
10
50
12
76
1.58
0.71
4.3
1.4
31.44
29.10
umol/l
0.08
12
71
308
2864
1.09
0.71
3.8
4.0
22.08
21.06
%
0.51
145
1312
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
7
42
1.67
0.68
1.0
1.0
—
—
—
0
0
66
560
1.19
0.65
1.6
1.4
—
—
—
0
0
7
44
1.59
0.65
1.1
1.3
—
—
—
0
0
7
44
1.59
0.65
1.1
1.3
—
—
—
0
0
10
62
1.62
0.65
1.3
1.3
253.50
442.42
u/l
—
10
55
8
49
1.64
0.62
1.4
1.3
—
—
—
0
0
34
274
1.25
0.57
1.1
1.1
2.03
3.21
u/ml
—
10
69
64
550
1.17
0.56
1.3
1.3
306.00
223.87
miu/ml
0.83
26
268
16
115
1.39
0.56
1.4
1.5
0.86
0.97
g/l
0.89
16
115
68
589
1.16
0.55
1.7
1.8
—
—
—
0
0
9
62
1.45
0.53
1.1
1.1
—
—
—
0
0
12
83
1.45
0.51
1.5
1.3
3781.67
21125.84
e6/l
—
6
45
28
224
1.25
0.51
1.2
1.1
—
—
—
0
0
15
109
1.38
0.51
4.4
2.5
—
—
—
0
0
76
858
0.88
0.49
1.3
1.3
—
—
—
0
0
7
46
1.52
0.48
1.4
1.2
—
—
—
0
0
7
47
1.49
0.47
1.7
1.3
10.65
8.84
ug/l
—
7
47
139
1275
1.10
0.47
2.4
2.5
31.32
76.67
u/l
0.64
123
1081
14
102
1.38
0.47
1.6
1.7
—
—
—
0
0
37
440
0.84
0.46
1.1
1.1
—
—
—
0
0
102
923
1.11
0.45
3.2
2.7
141.10
194.39
ng/l
0.89
91
832
385
3679
1.06
0.45
1.7
1.7
1.37
1.38
mmol/l
0.06
333
3131
15
112
1.34
0.44
1.7
1.6
—
—
—
0
0
43
502
0.85
0.44
1.3
1.4
—
—
—
0
0
108
983
1.11
0.44
1.7
1.8
—
—
—
0
0
43
501
0.85
0.43
1.3
1.4
—
—
—
0
0
43
500
0.86
0.43
1.3
1.4
—
—
—
0
0
8
56
1.43
0.42
3.1
1.6
—
—
—
0
0
43
499
0.86
0.42
1.3
1.4
—
—
—
0
0
8
60
1.33
0.40
2.1
2.1
154.88
150.44
nmol/l
—
8
52
38
443
0.85
0.40
1.1
1.1
—
—
—
0
0
55
484
1.14
0.39
1.2
1.4
—
—
—
0
0
0
19
0.00
0.39
0.0
11.3
—
6.69
—
0
19
9
66
1.37
0.38
1.0
1.3
—
75.00
—
0
12
135
1253
1.08
0.38
1.9
1.9
—
—
—
0
0
5
37
1.35
0.37
1.6
1.5
—
—
—
0
0
32
273
1.18
0.35
2.9
3.2
35.53
23.29
mg/l
0.59
15
169
35
302
1.16
0.34
1.3
1.3
275.44
234.32
u/ml
0.34
16
186
49
436
1.13
0.32
3.0
3.4
37.08
2979.89
u/ml
0.72
39
380
88
951
0.92
0.29
1.4
1.5
—
—
—
0
0
28
242
1.16
0.28
1.0
1.0
2.51
2.21
u/ml
0.12
13
114
140
1482
0.94
0.28
1.7
1.7
—
—
—
0
0
219
2096
1.05
0.27
2.8
2.9
0.72
0.74
ug/l
0.21
138
1340
22
257
0.85
0.26
2.2
1.5
—
—
—
0
0
24
210
1.14
0.21
1.3
1.4
6.44
7.36
mmol/l
0.68
11
146
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
33
298
1.11
0.19
1.7
2.5
0.72
0.84
nmol/l
0.80
27
253
11
90
1.22
0.19
1.4
1.6
6.57
7.45
ug/l
0.19
11
74
9
106
0.85
0.13
1.3
1.3
—
—
—
0
0
59
618
0.95
0.11
1.6
1.4
—
—
—
0
0
13
115
1.13
0.10
1.4
1.3
—
—
—
0
0
44
417
1.06
0.10
1.7
1.7
—
—
—
0
0
10
114
0.88
0.09
1.1
1.2
—
—
—
0
0
33
350
0.94
0.09
1.4
1.5
—
—
—
0
0
19
202
0.94
0.05
3.6
3.3
0.79
0.88
nmol/l
0.31
13
168
20
212
0.94
0.05
1.6
1.3
—
—
—
0
0
13
139
0.93
0.03
1.5
1.7
8.39
7.58
mmol/l
—
8
86
32
313
1.02
0.01
2.4
2.4
267.68
101.73
ug/min
0.71
18
190
63
626
1.01
0.00
1.7
1.7
4.14
3.80
mg/l
0.10
44
436
46
462
1.00
0.00
1.4
1.5
—
—
—
0
0
17
173
0.98
0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
7.99
—
0
6
0
5
0.00
0.00
0.0
1.0
—
1.80
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
7
71
0.99
0.00
1.3
1.2
54.00
16.19
u/l
—
7
62
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
7
73
0.96
0.00
1.4
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
0.00
1.4
3.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_ABNORMAL_FINDI_DIAGNOST_IMAGI_CENTRAL_NERVOUS_SYSTEM – Abnormal findings on diagnostic imaging of central nervous system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).